DE

The Future Map · technological enabler · active

3D Printing & Additive Manufacturing

Maturity

3 / 5

Basis, source, vintage

Genuine series production in narrow high-value niches; it has not displaced volume manufacturing and is not on track to.

Source: Fogarasi, Snodderly & Di Prima (FDA CDRH authors), Nature Reviews Bioengineering (2023): at least 357 additively manufactured devices received FDA 510(k) clearance 2010–2020, a ~1,900% rise across the decade; FDA recognises 18 AM consensus standards. GE Aerospace shipped its 100,000th 3D-printed LEAP fuel-nozzle tip (2021), part count cut from ~20 pieces to 1 and weight by ~25% (2010–2023)

What it is

Building objects by adding material layer by layer rather than cutting it away, in polymer, metal and increasingly concrete and biological material.

What it does

It removes tooling as a precondition for production, which makes small runs and distributed manufacture economically possible where they previously were not.

Common misconception

That it replaces mass manufacturing. It competes on complexity and small volume, not on unit cost at scale — and confusing the two produced a decade of overstated forecasts.

Steepens

A megatrend runs at the pace of its shallowest enabler. Marginal links are shown but never set the pace.

What would change its gradient

Shares megatrends with

In the book

Why the Future Arrives Unevenly — Ch. 5 — The Optimisation of Everything · Ch. 8 — The Rebuild of the Physical Base · Ch. 14 — How Hype Is Manufactured

Sources


See it in the map →

Cite this entry

Talin, B. (2026). 3D Printing & Additive Manufacturing. The Future Map, dataset v0.4.0 (2026-09-07). https://futuremap.talin.digital/e/3d-printing/

Machine view: This entry as Markdown · The whole map as JSON

Updated 2026-09-02.